Cutting Attrition Rates in Your CNS Clinical Trials




Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Summary: Dr. Wolfgang Eglmeier, Head of Clinical Operations Germany, GrĂ¼nenthal GmbH, joins Helen Winsor from Pharma IQ, to discuss optimising clinical development in CNS. He outlines the main challenges when recruiting for CNS trials and some strategies that can be employed to aid